NCT05599685View on ClinicalTrials.gov

A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (1)

15561

RECRUITING

Local Institution - 0001, Athens

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05599685 - A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter